Device for separating a blood component from blood or plasma

Liquid purification or separation – With means to add treating material – With distinct reactor tank – trough or compartment

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

2101981, 2103601, 2103801, 422 72, 436 45, 494 35, 494 43, 494 60, 604 6, B01D 2126

Patent

active

057387842

ABSTRACT:
A method and a device for separating a component, such as fibrin monomer from blood, by centrifugation, involve feeding of blood admixed an anticoagulant to a first annular chamber in a device, where the annular chamber is defined by a cylindrical outer wall and a cylindrical inner wall, both walls extending coaxially about a common axis, as well as by a top wall and a bottom wall. The top wall or the bottom wall is formed by a piston body displaceable within the first chamber. This method involves furthermore a centrifugation of the device about the said common axis to substantially separate blood into a cell fraction and a plasma fraction followed by the resulting plasma fraction being transferred while influenced by the piston body to a second chamber defined by an outer cylindrical wall. The outer cylindrical wall extends coaxially with the said common axis, whereby a fraction with fibrin I is caused to be separated in the second chamber while a suitable enzyme is being added. The separation of fibrin monomer from the plasma fraction in the second chamber is carried out during continued centrifugation whereby a fibrin polymer is deposited on the cylindrical outer wall of said second chamber, whereafter the fluid fraction collected at the bottom of the second chamber is transferred while influenced by the piston body to the first chamber. The fraction with fibrin polymer remaining in the second chamber is substantially deposited on the cylindrical wall and is caused to be dissolved by addition of a solvent and by centrifugation, whereafter it is transferred to a receiving container by passing after addition of a binder to the enzyme through a filter removing said enzyme, whereby a fibrin monomer containing solution is provided.

REFERENCES:
patent: 3064647 (1962-11-01), Earl
patent: 3078847 (1963-02-01), Wandell et al.
patent: 3799342 (1974-03-01), Greenspan
patent: 3908893 (1975-09-01), Williams
patent: 3911918 (1975-10-01), Turner
patent: 3932277 (1976-01-01), McDermott et al.
patent: 4086924 (1978-05-01), Latham, Jr.
patent: 4141887 (1979-02-01), Seufert
patent: 4300717 (1981-11-01), Latham, Jr.
patent: 4359049 (1982-11-01), Redl et al.
patent: 4471888 (1984-09-01), Herb et al.
patent: 4530691 (1985-07-01), Brown
patent: 4566610 (1986-01-01), Herb
patent: 4596657 (1986-06-01), Wisdom
patent: 4666429 (1987-05-01), Stone
patent: 4668399 (1987-05-01), Duggins
patent: 4729829 (1988-03-01), Duggins
patent: 4735726 (1988-04-01), Duggins
patent: 4767396 (1988-08-01), Powers
patent: 4784157 (1988-11-01), Halls et al.
patent: 4795441 (1989-01-01), Bhatt
patent: 4810378 (1989-03-01), Carmen et al.
patent: 4818386 (1989-04-01), Burns
patent: 4828716 (1989-05-01), McEwen et al.
patent: 4902281 (1990-02-01), Avoy
patent: 4934827 (1990-06-01), Taschke et al.
patent: 5030215 (1991-07-01), Morse et al.
patent: 5061381 (1991-10-01), Burd
patent: 5100372 (1992-03-01), Headley
patent: 5137181 (1992-08-01), Keller

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Device for separating a blood component from blood or plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Device for separating a blood component from blood or plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for separating a blood component from blood or plasma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-632230

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.